INBS Scorecard | INTELLIGENT BIO SOLUTIONS INC.

INTELLIGENT BIO SOLUTIONS INC. (INBS) Scorecard

2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.

40 QUARTERS × 3 ROAST BATTLES

14/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	LoseINBS / S&P -31.39% / 15.20%	WinINBS / S&P 38.09% / 15.00%	LoseINBS / S&P -58.63% / 50.40%
2026-Q11/3	LoseINBS / S&P -64.90% / -4.33%	WinINBS / S&P 33.26% / 11.30%	LoseINBS / S&P -7.34% / 27.70%
2025-Q42/3	LoseINBS / S&P -6.57% / 2.65%	WinINBS / S&P 18.14% / 9.00%	WinINBS / S&P 71.30% / 13.40%
2025-Q31/3	LoseINBS / S&P -40.70% / 8.12%	LoseINBS / S&P 3.26% / 4.61%	WinINBS / S&P 251.27% / 13.45%
2025-Q21/3	WinINBS / S&P 19.44% / 10.94%	LoseINBS / S&P -1.90% / 4.83%	LoseINBS / S&P -9.73% / 10.63%
2025-Q11/3	WinINBS / S&P 2.86% / -4.27%	LoseINBS / S&P 3.87% / 4.98%	LoseINBS / S&P -74.81% / 10.57%
2024-Q41/3	LoseINBS / S&P -19.08% / 2.41%	WinINBS / S&P 23.21% / 5.25%	LoseINBS / S&P -93.57% / 6.15%
2024-Q31/3	LoseINBS / S&P -9.90% / 5.89%	WinINBS / S&P 55.29% / 5.89%	LoseINBS / S&P -96.41% / 6.11%
2024-Q21/3	LoseINBS / S&P -54.50% / 4.28%	WinINBS / S&P 98.43% / 5.38%	LoseINBS / S&P -84.09% / 5.12%
2024-Q11/3	LoseINBS / S&P 4.04% / 10.56%	WinINBS / S&P 137.19% / 5.71%	LoseINBS / S&P INBS unavailable / 5.59%
2023-Q41/3	LoseINBS / S&P -67.18% / 11.69%	WinINBS / S&P 165.31% / 6.81%	LoseINBS / S&P INBS unavailable / 7.78%
2023-Q31/3	LoseINBS / S&P -62.95% / -3.27%	WinINBS / S&P 174.29% / 7.52%	LoseINBS / S&P INBS unavailable / -5.03%
2023-Q20/3	LoseINBS / S&P -4.14% / 8.74%	LoseINBS / S&P INBS unavailable / 9.50%	LoseINBS / S&P INBS unavailable / -8.57%
2023-Q10/3	LoseINBS / S&P -27.50% / 7.50%	LoseINBS / S&P INBS unavailable / 10.77%	LoseINBS / S&P INBS unavailable / -15.69%
2022-Q40/3	LoseINBS / S&P -52.38% / 7.56%	LoseINBS / S&P INBS unavailable / 11.88%	LoseINBS / S&P INBS unavailable / -17.99%
2022-Q30/3	LoseINBS / S&P -36.56% / -4.88%	LoseINBS / S&P INBS unavailable / 13.47%	LoseINBS / S&P INBS unavailable / -1.41%
2022-Q21/3	WinINBS / S&P -15.35% / -16.10%	LoseINBS / S&P INBS unavailable / 13.71%	LoseINBS / S&P INBS unavailable / 11.04%
2022-Q10/3	LoseINBS / S&P -45.51% / -4.60%	LoseINBS / S&P INBS unavailable / 15.97%	LoseINBS / S&P INBS unavailable / 42.23%
2021-Q40/3	LoseINBS / S&P -43.06% / 11.03%	LoseINBS / S&P INBS unavailable / 15.00%	LoseINBS / S&P INBS unavailable / 96.40%
2021-Q30/3	LoseINBS / S&P -36.04% / 0.58%	LoseINBS / S&P INBS unavailable / 10.77%	LoseINBS / S&P INBS unavailable / 69.42%
2021-Q20/3	LoseINBS / S&P -30.27% / 8.55%	LoseINBS / S&P INBS unavailable / 6.58%	LoseINBS / S&P INBS unavailable / 51.81%
2021-Q10/3	LoseINBS / S&P -23.65% / 6.17%	LoseINBS / S&P INBS unavailable / -1.06%	LoseINBS / S&P INBS unavailable / 7.39%
2020-Q40/3	LoseINBS / S&P INBS unavailable / 12.15%	LoseINBS / S&P INBS unavailable / -3.72%	LoseINBS / S&P INBS unavailable / -33.42%
2020-Q30/3	LoseINBS / S&P INBS unavailable / 8.93%	LoseINBS / S&P INBS unavailable / -2.04%	LoseINBS / S&P INBS unavailable / -27.10%
2020-Q20/3	LoseINBS / S&P INBS unavailable / 20.54%	LoseINBS / S&P INBS unavailable / -0.46%	LoseINBS / S&P INBS unavailable / -27.11%
2020-Q10/3	LoseINBS / S&P INBS unavailable / -19.60%	LoseINBS / S&P INBS unavailable / 3.47%	LoseINBS / S&P INBS unavailable / -14.75%
2019-Q40/3	LoseINBS / S&P INBS unavailable / 9.07%	LoseINBS / S&P INBS unavailable / 5.36%	LoseINBS / S&P INBS unavailable / 2.99%
2019-Q30/3	LoseINBS / S&P INBS unavailable / 1.70%	LoseINBS / S&P INBS unavailable / 5.02%	LoseINBS / S&P INBS unavailable / 0.21%
2019-Q20/3	LoseINBS / S&P INBS unavailable / 4.30%	LoseINBS / S&P INBS unavailable / 6.64%	LoseINBS / S&P INBS unavailable / 8.65%
2019-Q10/3	LoseINBS / S&P INBS unavailable / 13.65%	LoseINBS / S&P INBS unavailable / 8.12%	LoseINBS / S&P INBS unavailable / 14.29%
2018-Q40/3	LoseINBS / S&P INBS unavailable / -13.52%	LoseINBS / S&P INBS unavailable / 9.05%	LoseINBS / S&P INBS unavailable / 18.23%
2018-Q30/3	LoseINBS / S&P INBS unavailable / 7.71%	LoseINBS / S&P INBS unavailable / 10.21%	LoseINBS / S&P INBS unavailable / 19.06%
2018-Q20/3	LoseINBS / S&P INBS unavailable / 3.43%	LoseINBS / S&P INBS unavailable / 9.03%	LoseINBS / S&P INBS unavailable / 14.46%
2018-Q10/3	LoseINBS / S&P INBS unavailable / -0.76%	LoseINBS / S&P INBS unavailable / 7.68%	LoseINBS / S&P INBS unavailable / 12.46%
2017-Q40/3	LoseINBS / S&P INBS unavailable / 6.64%	LoseINBS / S&P INBS unavailable / 7.03%	LoseINBS / S&P INBS unavailable / 13.82%
2017-Q30/3	LoseINBS / S&P INBS unavailable / 4.48%	LoseINBS / S&P INBS unavailable / 5.68%	LoseINBS / S&P INBS unavailable / 17.57%
2017-Q20/3	LoseINBS / S&P INBS unavailable / 3.09%	LoseINBS / S&P INBS unavailable / 4.83%	LoseINBS / S&P INBS unavailable / 17.74%
2017-Q10/3	LoseINBS / S&P INBS unavailable / 6.07%	LoseINBS / S&P INBS unavailable / 3.67%	LoseINBS / S&P INBS unavailable / 13.32%
2016-Q40/3	LoseINBS / S&P INBS unavailable / 3.82%	LoseINBS / S&P INBS unavailable / 2.09%	LoseINBS / S&P INBS unavailable / 7.05%
2016-Q30/3	LoseINBS / S&P INBS unavailable / 3.85%	LoseINBS / S&P INBS unavailable / 0.20%	LoseINBS / S&P INBS unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	INBS total return	S&P 500 Total Return Index
Total return	-85.99%	20.78%
Annualized return	-85.99%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	INBS total return	S&P 500 Total Return Index
Total return	-99.97%	83.14%
Annualized return	-80.95%	12.86%

10Y · 2020-12-23 to 2026-08-27

Metric	INBS total return	S&P 500 Total Return Index
Total return	-99.99%	319.30%
Annualized return	-60.79%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Sonoma Pharmaceuticals, Inc. (SNOA)	United States	$0.006B	-2.59
AETHLON MEDICAL INC (AEMD)	United States	$0.005B
enVVeno Medical Corp (NVNO)	United States	$0.006B	-0.48
Bluejay Diagnostics, Inc. (BJDX)	United States	$0.004B
OSR Health, Inc. (OSRH)	United States	$0.004B	-0.75
Adagio Medical Holdings, Inc. (ADGM)	United States	$0.004B
Autonomix Medical, Inc. (AMIX)	United States	$0.004B
Co-Diagnostics, Inc. (CODX)	United States	$0.007B	-0.32
Beyond Air, Inc. (XAIR)	United States	$0.003B	-0.01
Vivos Therapeutics, Inc. (VVOS)	United States	$0.003B	-0.26